Skip to main content
Premium Trial:

Request an Annual Quote

Stratagene to Appeal Third Wave Patent Infringement Ruling, Sues Third Wave for Infringement

NEW YORK, Sept. 5 (GenomeWeb News) - Stratagene said last week that it will appeal a recent court decision that found the company had infringed patents held by Third Wave Technologies.

 

As reported by GenomeWeb News, last week a jury has determined that Stratagene's quantitative PCR and RT-PCR reagents using its FullVelocity technology infringe two patents held by Third Wave Technologies as part of its Invader technology.

 

Stratagene said that it was informed that the jury had awarded Third Wave $5.29 million in damages. The company said that the jury's verdict and the damages awarded were not supported by the facts of the case and, as a result, it will appeal the decision.

 

Stratagene also said that it has served Third Wave with a patent infringement suit filed in May. That suit alleges Third Wave has infringed certain Stratagene technology related to the quantitative detection of nucleic acids, and seeks monetary damages and a permanent injunction against continued infringement.

 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.